{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T05:08:34Z","timestamp":1793423314548,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["JAINR19A0"],"award-info":[{"award-number":["JAINR19A0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["JAIN20Y7"],"award-info":[{"award-number":["JAIN20Y7"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["CHEST"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.chest.2024.09.019","type":"journal-article","created":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T16:21:03Z","timestamp":1727454063000},"page":"348-361","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Impact of Cystic Fibrosis Transmembrane Conductance Regulator Modulators on Maternal Outcomes During and After Pregnancy"],"prefix":"10.1016","volume":"167","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2407-7374","authenticated-orcid":false,"given":"Raksha","family":"Jain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6355-8445","authenticated-orcid":false,"given":"Giselle","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4329-506X","authenticated-orcid":false,"given":"MinJae","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Keller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3861-5866","authenticated-orcid":false,"given":"Sophia","family":"Cosmich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2127-1218","authenticated-orcid":false,"given":"Sarthak","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0025-2422","authenticated-orcid":false,"given":"Natalie E.","family":"West","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3916-8260","authenticated-orcid":false,"given":"Traci M.","family":"Kazmerski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6785-5076","authenticated-orcid":false,"given":"Jennifer L.","family":"Goralski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1560-6879","authenticated-orcid":false,"given":"Patrick A.","family":"Flume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea H.","family":"Roe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8602-9503","authenticated-orcid":false,"given":"Denis","family":"Hadjiliadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet","family":"Uluer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila","family":"Mody","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2867-5619","authenticated-orcid":false,"given":"Sigrid","family":"Ladores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5436-9722","authenticated-orcid":false,"given":"Jennifer L.","family":"Taylor-Cousar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.chest.2024.09.019_bib1","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1908639","article-title":"Elexacaftor-tezacaftor-ivacaftor for cystic fibrosis with a single Phe508del allele","volume":"381","author":"Middleton","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"10212","key":"10.1016\/j.chest.2024.09.019_bib2","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/S0140-6736(19)32597-8","article-title":"Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial","volume":"394","author":"Heijerman","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.chest.2024.09.019_bib3","unstructured":"Cystic Fibrosis Foundation Patient Registry. 2022 Annual Data Report. Bethesda, Maryland."},{"issue":"4","key":"10.1016\/j.chest.2024.09.019_bib4","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1007\/s10995-016-2181-z","article-title":"Attitudes and decision making related to pregnancy among young women with cystic fibrosis","volume":"21","author":"Kazmerski","year":"2017","journal-title":"Matern Child Health J"},{"issue":"9","key":"10.1016\/j.chest.2024.09.019_bib5","first-page":"2706","article-title":"CFTR modulators: impact on fertility, pregnancy, and lactation in women with cystic fibrosis","volume":"9","author":"Taylor-Cousar","year":"2020","journal-title":"J\u00a0Clin Med"},{"issue":"5","key":"10.1016\/j.chest.2024.09.019_bib6","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.jcf.2023.03.013","article-title":"Cervical mucus quality in females with and without cystic fibrosis","volume":"22","author":"Roe","year":"2023","journal-title":"J\u00a0Cyst Fibros"},{"issue":"5","key":"10.1016\/j.chest.2024.09.019_bib7","first-page":"418","article-title":"Fertility, pregnancy and lactation considerations for women with CF in the CFTR modulator era","volume":"11","author":"Jain","year":"2021","journal-title":"J\u00a0Pers Med"},{"issue":"5","key":"10.1016\/j.chest.2024.09.019_bib8","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.jcf.2023.03.020","article-title":"Association between unplanned pregnancies and maternal exacerbations in cystic fibrosis","volume":"22","author":"Peng","year":"2023","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.chest.2024.09.019_bib9","first-page":"S1","article-title":"Maternal and fetal outcomes in the era of CFTR modulators (MAYFLOWERS) study: interim results","volume":"22S3","author":"Jain","year":"2023","journal-title":"J Cyst Fibros"},{"issue":"4","key":"10.1016\/j.chest.2024.09.019_bib10","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1378\/chest.124.4.1460","article-title":"The effect of pregnancy on survival in women with cystic fibrosis","volume":"124","author":"Goss","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.chest.2024.09.019_bib11","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.rmed.2018.11.009","article-title":"A\u00a0case-control study on pregnancy in Italian cystic fibrosis women. Data from the Italian\u00a0Registry","volume":"145","author":"Giordani","year":"2018","journal-title":"Respir Med"},{"issue":"13","key":"10.1016\/j.chest.2024.09.019_bib12","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1111\/1471-0528.16423","article-title":"The outcome of pregnancy in women with cystic fibrosis: a UK population-based descriptive study","volume":"127","author":"Ashcroft","year":"2020","journal-title":"BJOG"},{"issue":"1","key":"10.1016\/j.chest.2024.09.019_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2014.07.018","article-title":"Medical and obstetric complications among pregnant women with cystic fibrosis","volume":"212","author":"Patel","year":"2015","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.chest.2024.09.019_bib14","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1513\/AnnalsATS.201211-108OC","article-title":"Long-term effects of pregnancy and motherhood on disease outcomes of women with cystic fibrosis","volume":"10","author":"Schechter","year":"2013","journal-title":"Ann Am Thorac Soc"},{"issue":"2","key":"10.1016\/j.chest.2024.09.019_bib15","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1177\/1753495X15575628","article-title":"Pregnancy outcomes in cystic fibrosis: a 10-year experience from a UK centre","volume":"8","author":"Renton","year":"2015","journal-title":"Obstet Med"},{"issue":"3","key":"10.1016\/j.chest.2024.09.019_bib16","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jcf.2020.09.002","article-title":"Baseline cystic fibrosis disease severity has an adverse impact on pregnancy and infant outcomes, but does not impact disease progression","volume":"20","author":"Cohen-Cymberknoh","year":"2021","journal-title":"J\u00a0Cyst Fibros"},{"issue":"1","key":"10.1016\/j.chest.2024.09.019_bib17","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1378\/chest.118.1.85","article-title":"Pregnancy in cystic fibrosis. Fetal and maternal outcome","volume":"118","author":"Gilljam","year":"2000","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.chest.2024.09.019_bib18","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jcf.2013.08.004","article-title":"Cystic fibrosis and pregnancy in the modern era: a case control study","volume":"13","author":"Ahluwalia","year":"2014","journal-title":"J\u00a0Cyst Fibros"},{"issue":"4","key":"10.1016\/j.chest.2024.09.019_bib19","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jcf.2020.02.018","article-title":"Outcomes of pregnancy in women with cystic fibrosis (CF) taking CFTR modulators\u2014an international survey","volume":"19","author":"Nash","year":"2020","journal-title":"J\u00a0Cyst Fibros"},{"issue":"3","key":"10.1016\/j.chest.2024.09.019_bib20","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.jcf.2021.03.006","article-title":"Maternal and fetal outcomes following elexacaftor-tezacaftor-ivacaftor use during pregnancy and lactation","volume":"20","author":"Taylor-Cousar","year":"2021","journal-title":"J\u00a0Cyst Fibros"},{"issue":"2","key":"10.1016\/j.chest.2024.09.019_bib21","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J\u00a0Biomed Inform"},{"issue":"suppl 1","key":"10.1016\/j.chest.2024.09.019_bib22","first-page":"S79","article-title":"Entering the era of highly effective modulator therapies","volume":"56","author":"Dave","year":"2021","journal-title":"Pediatr Pulmonol"},{"issue":"3","key":"10.1016\/j.chest.2024.09.019_bib23","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1001\/jamapediatrics.2023.5718","article-title":"Recommendations for reporting research about racial disparities in medical and scientific journals","volume":"178","author":"Duncan","year":"2024","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.chest.2024.09.019_bib25","doi-asserted-by":"crossref","unstructured":"American Academy of Pediatrics Committee on Fetus and Newborn, American College of Obstetricians and Gynecologists Committee On Obstetric Practice; Watterberg KL, et\u00a0al. The Apgar score. Pediatrics. 2015;136(4):819-822.","DOI":"10.1542\/peds.2015-2651"},{"issue":"6","key":"10.1016\/j.chest.2024.09.019_bib26","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.jcf.2017.01.008","article-title":"Pregnancy among cystic fibrosis women in the era of CFTR modulators","volume":"16","author":"Heltshe","year":"2017","journal-title":"J\u00a0Cyst Fibros"},{"issue":"6","key":"10.1016\/j.chest.2024.09.019_bib27","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1055\/s-0039-1697975","article-title":"Acute pulmonary exacerbations in cystic fibrosis","volume":"40","author":"Goss","year":"2019","journal-title":"Semin Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.chest.2024.09.019_bib28","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/ppul.21374","article-title":"Pulmonary exacerbations are associated with subsequent FEV1 decline in both adults and children with cystic fibrosis","volume":"46","author":"Sanders","year":"2011","journal-title":"Pediatr Pulmonol"},{"issue":"4","key":"10.1016\/j.chest.2024.09.019_bib29","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.jcf.2018.10.009","article-title":"Failure to conceive in women with CF is associated with pancreatic insufficiency and advancing age","volume":"18","author":"Shteinberg","year":"2019","journal-title":"J\u00a0Cyst Fibros"},{"issue":"1","key":"10.1016\/j.chest.2024.09.019_bib30","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jcf.2019.06.003","article-title":"Pregnancy outcome in women with cystic fibrosis and poor pulmonary function","volume":"19","author":"Reynaud","year":"2020","journal-title":"J\u00a0Cyst Fibros"},{"issue":"1","key":"10.1016\/j.chest.2024.09.019_bib31","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jcf.2020.04.008","article-title":"Average rate of lung function decline in adults with cystic fibrosis in the United Kingdom: data from the UK CF registry","volume":"20","author":"Caley","year":"2021","journal-title":"J\u00a0Cyst Fibros"},{"issue":"2","key":"10.1016\/j.chest.2024.09.019_bib32","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/ppul.21526","article-title":"Lung function decline from adolescence to young adulthood in cystic fibrosis","volume":"47","author":"Vandenbranden","year":"2012","journal-title":"Pediatr Pulmonol"},{"issue":"1","key":"10.1016\/j.chest.2024.09.019_bib33","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jcf.2016.07.012","article-title":"Reduced survival in adult cystic fibrosis despite attenuated lung function decline","volume":"16","author":"Keating","year":"2017","journal-title":"J\u00a0Cyst Fibros"},{"issue":"3","key":"10.1016\/j.chest.2024.09.019_bib34","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.jcf.2022.12.009","article-title":"Effect of elexacaftor\/tezacaftor\/ivacaftor on annual rate of lung function decline in people with cystic fibrosis","volume":"22","author":"Lee","year":"2023","journal-title":"J\u00a0Cyst Fibros"},{"issue":"7","key":"10.1016\/j.chest.2024.09.019_bib35","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1164\/rccm.201503-0578OC","article-title":"Sustained benefit from ivacaftor demonstrated by combining clinical trial and cystic fibrosis patient registry data","volume":"192","author":"Sawicki","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.chest.2024.09.019_bib36","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3109\/14767058.2016.1161747","article-title":"Maternal co-morbidities and neonatal outcomes associated with cystic fibrosis","volume":"30","author":"Jelin","year":"2017","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"issue":"4","key":"10.1016\/j.chest.2024.09.019_bib37","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jcf.2021.12.004","article-title":"Drug exposure to infants born to mothers taking elexacaftor, tezacaftor, and ivacaftor","volume":"21","author":"Collins","year":"2022","journal-title":"J\u00a0Cyst Fibros"},{"issue":"6","key":"10.1016\/j.chest.2024.09.019_bib38","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.jcf.2018.05.009","article-title":"Measured fetal and neonatal exposure to Lumacaftor and Ivacaftor during pregnancy and while breastfeeding","volume":"17","author":"Trimble","year":"2018","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.chest.2024.09.019_bib39","unstructured":"Vertex Pharmaceuticals Inc. Trikafta. Vertex Treatments Finder website. Accessed August 1, 2024. https:\/\/pi.vrtx.com\/files\/uspi_elexacaftor_tezacaftor_ivacaftor.pdf"},{"issue":"6","key":"10.1016\/j.chest.2024.09.019_bib40","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.jcf.2022.10.004","article-title":"Congenital bilateral cataracts in newborns exposed to elexacaftor-tezacaftor-ivacaftor in utero and while breast feeding","volume":"21","author":"Jain","year":"2022","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.chest.2024.09.019_bib41","article-title":"Role of maternal age and pregnancy history in risk of miscarriage: prospective register based study","volume":"364","author":"Magnus","year":"2019","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.chest.2024.09.019_bib42","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-03183-1","article-title":"Trends in neonatal intensive care unit admissions by race\/ethnicity in the United States, 2008-2018","volume":"11","author":"Kim","year":"2021","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.chest.2024.09.019_bib46","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2022-001289","article-title":"Prospectively evaluating maternal and fetal outcomes in the era of CFTR modulators: the MAYFLOWERS observational clinical trial study design","volume":"9","author":"Jain","year":"2022","journal-title":"BMJ Open Respir Res"}],"container-title":["CHEST"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369224052759?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369224052759?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T21:32:16Z","timestamp":1777411936000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369224052759"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S0012369224052759"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2024.09.019","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of Cystic Fibrosis Transmembrane Conductance Regulator Modulators on Maternal Outcomes During and After Pregnancy","name":"articletitle","label":"Article Title"},{"value":"CHEST","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2024.09.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American College of Chest Physicians. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}